Geistlich Pharma North America, Inc.
Shannon Ortega has a diverse work experience in finance and accounting. Shannon started their career at BAYADA Home Health Care as an Accounting Associate and Collections Associate from 2010 to 2014. Shannon then joined Geistlich Biomaterials - North America in 2014, where they held various roles including Finance Associate, Senior Accountant, Accounting Manager, and Senior Accounting Manager until 2022. Following that, they worked as a Senior Accountant at LaFata Contract Services, LLC from September 2022 to March 2023. Currently, they are the Director of Finance at Geistlich Pharma North America, Inc. since January 2023.
Shannon Ortega obtained a Master's degree in Accounting and Finance from Rutgers University in the years 2013 to 2017. Prior to that, Shannon attended Stockton University from 2006 to 2009, though no specific degree or field of study was mentioned. Shannon also completed their high school education at Burlington Township High School, but there is no information regarding the years attended or the degree or field of study pursued.
This person is not in any teams
This person is not in any offices
Geistlich Pharma North America, Inc.
Geistlich Pharma North America, Inc., is an affiliate of Geistlich Pharma AG who produce and distribute medical devices and pharmaceuticals for regenerative medicine in Wolhusen and Root, Switzerland. The Swiss company forms part of the Geistlich group which has been in family hands since 1851. Geistlich Pharma and its 3 business units Geistlich Biomaterials, Geistlich Surgery, Geistlich Medical have 10 subsidiaries and global distribution, over 500 employees worldwide and is a world leader in regenerative dentistry through its business unit Geistlich Biomaterials. Geistlich continues to lead oral regeneration based upon our history of quality, scientific collaboration, and manufacturing excellence. Every Geistlich biomaterial is intentionally designed for a specific application and carefully engineered to preserve its natural structures. Today, our full product portfolio of Bone Substitutes, Membranes, and Matrices increases clinical flexibility and expands treatment options in a variety of therapeutic areas. Geistlich Bio-Oss®: Derived from bovine bone and preserved through a unique, patented process, making it highly similar to human bone. Geistlich Bio-Oss® remains the essential choice among an expanding range of therapeutic areas through its unique properties and reliable clinical outcomes. Geistlich Bio-Gide®: A unique bilayer collagen membrane designed to ensure optimal regenerative healing of bone and soft tissue. It provides excellent wound stability and graft containment with optimal protection for bone regeneration. Geistlich Mucograft®: A collagen matrix designed for gain of keratinized tissue and recession coverage where open healing is required. Geistlich Fibro-Gide®: The first volume-stable collagen matrix designed for soft-tissue augmentation around natural teeth and implants as a submerged scaffold where an increase in soft-tissue thickness is clinically desired.